SESSION INTENT

SUMMARY

• The user requested a downloadable .pptx deck on amphetamine/addiction medicine, with photos, maximum 10–12 slides.
• No PowerPoint file has been created yet; research and tool-skill review were in progress.
• The medical-library skill was invoked as required for clinical content. Key textbook-derived facts identified:
  • Lippincott Illustrated Reviews: Pharmacology: amphetamine has psychological and physical dependence potential; tolerance may emerge within weeks; therapeutic utility limited by psychological/physiological dependence.
  • Tietz Textbook of Laboratory Medicine: amphetamine/methamphetamine increase blood pressure, heart rate, body temperature, and motor activity; relax bronchial smooth muscle; suppress appetite; abuse can produce strong psychological dependence and marked tolerance.
  • Tintinalli Emergency Medicine: chronic use may downregulate dopamine receptor activity and contribute to withdrawal; mortality in toxicity may result from hyperthermia, dysrhythmias, seizures, hypertension (including intracranial hemorrhage/infarction), and encephalopathy; long-term abuse/withdrawal may cause profound paranoid psychosis.
  • Maudsley Prescribing Guidelines: withdrawal syndrome is common in dependence; symptoms can include low mood, listlessness, agitation, irritability, and fatigue; treatment is mainly symptomatic.
  • Kaplan & Sadock: no reliably effective specific pharmacologic treatments for cocaine/amphetamine intoxication or withdrawal; supportive care is the mainstay.
  • Goodman & Gilman: acute intoxication management may include sedation for CNS symptoms and management of severe hypertension; however, current deck should prioritize standard, safe contemporary clinical messaging rather than presenting urine acidification as routine management.
  • Adams and Victor’s Neurology: high-dose IV amphetamine can cause immediate euphoria; acute/chronic intoxication is clinically significant.
• External evidence/guideline research:
  • WHO mhGAP evidence profile: most evidence-based treatment approaches for cocaine/amphetamine-type stimulant dependence are non-pharmacological, especially contingency management and cognitive behavioural therapy; no medication is broadly regulatory-approved specifically for stimulant dependence. It notes associated psychosis, heart disease, cognitive impairment, overdose, HIV/hepatitis C risk, and social/legal harms.
  • UNODC treatment document: evidence for pharmacologic strategies remains limited; psychosocial treatment is essential. Older/limited evidence discussed extended-release methylphenidate/modafinil and supervised psychostimulant strategies, but these should be presented as specialist/selected-context evidence rather than standard pharmacotherapy.
  • PubMed reviews found:
    • 2026 systematic review/meta-analysis: amphetamine-type stimulant use associated with suicide and psychiatric disorders (PMID 41908112).
    • 2025 systematic review/meta-analysis: naltrexone for amphetamine-type stimulant use disorder (PMID 39591619).
    • 2024 systematic review/meta-analysis: prescription psychostimulants for amphetamine-type stimulant use disorder (PMID 37880829).
• Recommended deck framing: clinical, non-stigmatizing, MBBS-level, emphasizing:
  1. Definition/classification and legitimate medical uses
  2. Pharmacology / dopamine-noradrenaline mechanism
  3. Routes and patterns of misuse
  4. Acute intoxication features
  5. Chronic complications
  6. Amphetamine/stimulant use disorder and withdrawal
  7. Emergency assessment/management
  8. Long-term treatment: contingency management, CBT, psychosocial care, relapse prevention
  9. Harm reduction and comorbidity screening
  10. Key take-home points/references
  • This fits 10 slides, with potential 11th slide for a short clinical case or reference list.
• Visual research:
  • search_image for “amphetamine drug addiction brain reward pathway dopamine clinical diagram” returned no direct results.
  • Web image search found potentially usable Wikimedia images:
    • https://thumb.wikimedia.org/wikipedia/commons/thumb/0/0e/Amph_salts.jpg/250px-Amph_salts.jpg?utm_source=en.wikipedia.org&utm_campaign=parser&utm_content=thumbnail
    • https://upload.wikimedia.org/wikipedia/commons/f/f4/Amphetamine.jpg?utm_source=commons.wikimedia.org&utm_campaign=index&utm_content=original
    • Wikimedia Commons page: https://commons.wikimedia.org/wiki/File:Amphetamine-Adipex_37.5mg.jpg — public domain, USDOJ source, amphetamine/Adipex tablets.
    • Wikimedia Commons page: https://commons.wikimedia.org/wiki/File:Amphetamine-2D-skeletal.svg — chemical structure, available under a free license.
    • Wikimedia Commons page: https://commons.wikimedia.org/wiki/File:Amphetaminsulfat-d-l-10mg.jpg — CC BY-SA/GFDL capsule image.
  • Avoid Getty and Science Photo images unless licensing is confirmed. Use public-domain/free-license Wikimedia visuals or create original diagrams with PowerPoint shapes.
• PPTX skill was invoked. Important implementation rules:
  • Use python-pptx to create from scratch, with blank layout.
  • Use 16:9 widescreen: Inches(13.333) × Inches(7.5).
  • When embedding URL-based images, must use /tmp/skills/shared/scripts/fetch_images.py, not custom download code.
  • For verification after creation, use python-pptx to inspect slide text; render/check slides visually if possible.
• Workspace listing showed only /tmp/workspace/attachments; no existing template or source presentation was provided.

ARTIFACTS

• No final deck or other user-facing artifact has been created.
• Skills/resources accessed:
  • /skills/readonly/medical-library/SKILL.md
  • /tmp/skills/pptx/SKILL.md
  • /tmp/skills/pptx/python-pptx.md
• Medical textbook sources queried through the library database, including:
  • Lippincott Illustrated Reviews Pharmacology
  • Tietz Textbook of Laboratory Medicine
  • Tintinalli’s Emergency Medicine
  • The Maudsley Prescribing Guidelines in Psychiatry
  • Kaplan & Sadock’s Comprehensive Textbook of Psychiatry
  • Goodman & Gilman’s The Pharmacological Basis of Therapeutics
  • Adams and Victor’s Principles of Neurology
• External source searches completed:
  • PubMed systematic reviews/meta-analyses on amphetamine use disorder.
  • WHO/UNODC web sources on stimulant use disorder treatment.
  • Wikimedia/web visual search for amphetamine images.
• Workspace accessed:
  • /tmp/workspace/attachments (directory only; no files reported).

NEXT STEPS

1. Create a polished 10–12 slide, 16:9 .pptx in /tmp/workspace/, likely named Amphetamine_Medicine_of_Addiction_MBBS.pptx.
2. Use a coherent medical visual theme and include a small number of legal/free photos (e.g., Wikimedia amphetamine tablet/capsule/chemical-structure visuals) plus original PowerPoint diagrams such as dopamine reward pathway and intoxication-vs-withdrawal comparison.
3. Ensure clinically accurate, non-stigmatizing MBBS-level content; clearly state that there is no universally approved medication specifically for stimulant use disorder and that contingency management/CBT/psychosocial interventions are core treatment approaches.
4. Include brief references on the final slide, citing WHO mhGAP, UNODC, and textbook/current systematic-review sources.
5. Validate the generated deck: check slide count, text overflow, image placement, and openability.
6. Provide the final downloadable file link/path to the user.

SESSION INTENT

SUMMARY

• User requested a downloadable PPT on “amphetamine,” medicine of addiction, MBBS level, with photos, max 10–12 slides.
• No presentation has yet been created or saved; research and skill review were completed.

Required tool/skill guidance reviewed

• Medical-library skill was invoked, as required for medical content.
  • Library navigation must use query_library_db to discover content; relevant textbook blocks were identified and partially read.
• PPTX skill was invoked.
  • Use python-pptx to create a deck from scratch.
  • Recommended dimensions: 16:9 widescreen (13.333 x 7.5 in) and blank slide layout index 6.
  • For URL images, the PPT skill says to use /tmp/skills/shared/scripts/fetch_images.py (rather than custom download code) then decode base64 for embedding.
  • Do not type Unicode bullet characters manually; use placeholders or appropriate XML/list formatting if necessary.
  • Need inspect/verify generated PPTX with python-pptx and ideally render/check slides if available.

Authoritative medical content collected

1. Mechanism / pharmacology
   Source: Lippincott Illustrated Reviews: Pharmacology, /textbooks/9781975170561/9781975170561_block3.md, lines 102–145.
   • Amphetamine elevates synaptic catecholamines primarily by releasing intracellular catecholamine stores.
   • Also inhibits MAO and is a weak reuptake transport inhibitor, yielding high synaptic catecholamine levels.
   • Major behavioral effects reflect dopamine and norepinephrine release enhancement.
   • CNS effects: increased alertness, decreased fatigue and appetite, insomnia; high doses may cause psychosis and convulsions.
   • Peripheral sympathetic effects occur indirectly through norepinephrine release.
   • The source contains an embedded mechanism diagram: https://cdn.orris.care/cdss_images/aef33bc79f17cd50a6d86793628d4620d370706b5825b999531ef8da7fc453f2.png This is a good educational visual for the mechanism slide; fetch it with the prescribed helper.
   • Therapeutic uses noted: ADHD, narcolepsy; some related sympathomimetics used as appetite suppressants. Abuse potential and Schedule II classification noted in US source.
   • Amphetamine fully absorbed orally, liver metabolized, urinary excretion; abuse routes include IV and smoking. Euphoria lasts about 4–6 h (longer than cocaine).
2. Dependence / tolerance
   Source: Lippincott same file, search result lines 137–145.
   • Long-term amphetamine use associated with psychological and physical dependence; tolerance can develop within weeks.
   • A slide should distinguish prescribed therapeutic use from non-medical use/use disorder without stigmatizing language.
3. Acute toxicity / emergency features
   Source: Tintinalli’s Emergency Medicine, /textbooks/9781260019933/9781260019933_block16.md, identified around lines 414–418 and 459–460.
   • Mortality in amphetamine toxicity can result from hyperthermia, dysrhythmias, seizures, hypertension (including intracranial hemorrhage/infarction), and encephalopathy.
   • Long-term abuse and withdrawal may be associated with profound paranoid psychosis.
   • Search result source: Frameworks for Internal Medicine says acute amphetamine intoxication resembles cocaine toxicity; tachycardia and hypertension are common.
   • Include a “red flags / emergency management” slide: agitation, hyperthermia, chest pain, seizures, severe HTN, altered consciousness require urgent ED care.
4. Withdrawal / acute management Source: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, /textbooks/9781975175733/9781975175733_block18.md, lines 2390–2399+.
   • Stimulant-related disorder treatment commonly begins outpatient because withdrawal rarely requires specific medical intervention.
   • Hospital/residential treatment may be needed for severe medical/psychiatric comorbidity, nonresponse in lower intensity care, unsafe environment, persistent psychosis, severe depression/suicidality, polydrug withdrawal, or medical complications.
   • No reliably effective specific pharmacological treatment for cocaine or amphetamine intoxication/withdrawal; supportive care is mainstay.
   • Intoxication may be complicated by paranoia, agitation, seizures, hypertension and sequelae, end-organ ischemia.
   • Short-term benzodiazepines or antipsychotic medication may be used for agitation/paranoia in monitored settings; many recover over hours to days. Source: Maudsley Prescribing Guidelines search result:
   • Withdrawal syndrome common in dependence; symptoms include low mood, listlessness, agitation, irritability, fatigue, usually short-lived.
   • Avoid claiming a universally approved medication for amphetamine withdrawal/use disorder.
5. Treatment of stimulant/amphetamine use disorder
   • WHO mhGAP evidence profile (web search) states most evidence-based treatments for cocaine/amphetamine-type stimulant dependence are non-pharmacological, notably contingency management and cognitive behavioural therapy; no regulatory-agency-approved medicine for stimulant dependence at time described.
   • UNODC source notes evidence is evolving for prescription psychostimulants, particularly extended-release methylphenidate, but evidence is limited and treatment should be clinician/specialist-directed and combined with psychosocial intervention.
   • PubMed recent evidence:
     • 2025 systematic review/meta-analysis, “Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder?” PMID 39591619, DOI 10.1097/ADM.0000000000001422.
     • 2024 systematic review/meta-analysis of prescription psychostimulants: PMID 37880829, DOI 10.1111/add.16347.
   • For an MBBS deck, frame pharmacotherapy as “no established approved medication; investigate/consider specialist-supervised approaches per local protocols,” rather than recommend a drug regimen.

Visual/photo resources found

• Image search itself for “amphetamine drug addiction brain reward pathway dopamine clinical diagram” yielded no direct results.
• Web image search located Wikimedia Commons/public-domain/CC resources:
  1. Adipex tablets image, public domain (USDOJ)
     Page: https://commons.wikimedia.org/wiki/File:Amphetamine-Adipex_37.5mg.jpg
     Search result says public domain; image of amphetamine Adipex 37.5 mg tablets.
  2. Amphetamine sulfate capsules, CC BY-SA/GFDL
     Page: https://commons.wikimedia.org/wiki/File:Amphetaminsulfat-d-l-10mg.jpg
  3. Amphetamine skeletal chemical structure, Commons SVG
     Page: https://commons.wikimedia.org/wiki/File:Amphetamine-2D-skeletal.svg
  4. Amphetamine powder photo
     Page: https://commons.wikimedia.org/wiki/File:Amphetamine_(Drug).jpg
  5. Search-returned likely image URL: https://upload.wikimedia.org/wikipedia/commons/f/f4/Amphetamine.jpg?utm_source=commons.wikimedia.org&utm_campaign=index&utm_content=original
• Need use only a limited number of purposefully selected visuals (e.g., title photo/tablet image, molecular structure, textbook mechanism image); do not glamorize substance use. Add a concise visual credit/source line in final references or speaker notes if possible.

Suggested slide structure (11 slides)

1. Title — Amphetamine: Medicine of Addiction (MBBS); modest tablet/photo + safety-focused subtitle.
2. Learning objectives / scope — pharmacology, clinical effects, toxicity, use disorder, management.
3. What is amphetamine? — CNS stimulant; prescription versus non-medical/illicit use; key derivatives/examples.
4. Mechanism of action — dopamine/norepinephrine release, MAO inhibition/weak reuptake inhibition; use textbook mechanism figure.
5. Acute effects and signs — euphoria/alertness, anorexia/insomnia; mydriasis, tachycardia, HTN, hyperthermia.
6. Harmful consequences — cardiovascular, neurologic, psychiatric, infectious/social risks based on route/risk behavior.
7. Amphetamine/stimulant use disorder — dependence, tolerance, craving; risk/protective considerations.
8. Withdrawal — “crash”: fatigue, dysphoria/low mood, sleep disturbance, irritability/agitation; assess suicidality/psychosis.
9. Acute intoxication: assessment and emergency treatment — ABCDE, temperature/glucose/ECG, supportive cooling/fluids, benzodiazepines for agitation/seizures per local protocol, escalation/red flags; no home detox instruction.
10. Long-term management — motivational intervention, contingency management, CBT, family/social support, harm reduction; comorbidity screening; no routinely approved pharmacotherapy.
11. Take-home messages + references — textbooks, WHO, UNODC, selected systematic reviews/image credits.

• Could reduce to 10 slides by merging “learning objectives” into title/intro or merging take-home points with references.
• Ensure clinically accurate, non-stigmatizing language and clearly mark emergency management as educational/local-protocol dependent.
• Avoid detail that would facilitate misuse (e.g., dosing, synthesis, route optimization).

ARTIFACTS

• No .pptx file or other output artifact has been created yet.
• No files in /tmp/workspace were created; directory listing showed only:
  • /tmp/workspace/attachments
• Resources accessed:
  • Medical library source blocks:
    • /textbooks/9781975170561/9781975170561_block3.md — Lippincott pharmacology, amphetamine mechanism/actions/uses.
    • /textbooks/9781260019933/9781260019933_block16.md — Tintinalli emergency medicine, amphetamine toxicity/withdrawal.
    • /textbooks/9781975175733/9781975175733_block18.md — Kaplan & Sadock treatment of stimulant intoxication/withdrawal.
  • PPT creation guide:
    • /tmp/skills/pptx/SKILL.md
    • /tmp/skills/pptx/python-pptx.md
  • Textbook mechanism image URL:
    • https://cdn.orris.care/cdss_images/aef33bc79f17cd50a6d86793628d4620d370706b5825b999531ef8da7fc453f2.png

NEXT STEPS

1. Create an 10–11 slide, 16:9 PowerPoint in /tmp/workspace using python-pptx.
2. Fetch selected images using the mandated helper script (/tmp/skills/shared/scripts/fetch_images.py), preferably the Lippincott mechanism image and a public-domain/CC Wikimedia tablet/structure visual.
3. Use the suggested slide plan and source-grounded content, keeping text concise and readable for MBBS students.
4. Add an appropriate reference/image-credit slide, including Lippincott, Tintinalli, Kaplan & Sadock, WHO mhGAP/UNODC, and image license attribution where needed.
5. Validate the .pptx (open/read via python-pptx; check slide count, text, embedded images, visual overflow if render tools are available).
6. Return a sandbox download link to the completed .pptx.